Characteristics | Any drug resistance | COR (95% CI) | p-value | ||
---|---|---|---|---|---|
Yes, n (%) | No, n (%) | Total, N (%) | |||
Sex | |||||
āMale | 10 (17.5) | 47 (82.5) | 57 (100) | 1.00 | Ā |
āFemale | 10 (18.5) | 44 (81.5) | 54 (100) | 1.06 (0.40ā2.81) | 1.00 |
AgeĀ (years) | |||||
ā5ā17 | 2 (18.2) | 9 (81.8) | 11 (100) | 1.00 | Ā |
ā18ā30 | 9 (21.4) | 33 (78.6) | 42 (100) | 1.22 (0.22ā6.72) | 0.813 |
ā31ā43 | 3 (8.8) | 31 (91.2) | 34 (100) | 0.43 (0.06ā3.02) | 0.390 |
ā44ā56 | 4 (22.2) | 14 (77.8) | 18 (100) | 1.28 (0.19ā8.53) | 0.794 |
āā>ā56 | 2 (33.3) | 4 (66.7) | 6 (100) | 2.25 (0.22ā22.14) | 0.481 |
Patient category | |||||
āNew cases | 15 (16.7) | 75 (83.3) | 90 (100) | 1.00 | Ā |
āRetreatment | 5 (23.8) | 16 (76.2) | 21 (100) | 1.56 (0.49ā4.92) | 0.443 |
Family TB history | |||||
āYes | 6 (16.7) | 30 (83.3) | 36 (100) | 1.00 | Ā |
āNo | 14 (18.7) | 61 (81.3) | 75 (100) | 1.14 (0.40ā3.28) | 0.797 |
Clinical presentation | |||||
āPTB | 11 (25.0) | 33 (75.0) | 44 (100) | 1.00 | Ā |
āEPTB | 9 (13.4) | 58 (86.6) | 67 (100) | 0.46 (0.17ā1.23) | 0.120 |